|1 Table of Contents 3
|1.1 List of Tables 7
|1.2 List of Figures 8
2 Introduction 10
2.1 What Is This Report About? 10
2.2 IVD Analyzers Market Segmentation 10
2.3 Definitions of Markets Covered in the Report 11
3 IVD Analyzers Market, EU5 15
3.1 IVD Analyzers Market, EU5, Revenue ($m), 2018-2033 15
3.2 IVD Analyzers Market, EU5, Revenue ($m), 2018-2033 16
3.3 IVD Analyzers Market, EU5, Volume (Units), 2018-2033 19
3.4 IVD Analyzers Market, EU5, Volume (Units), 2018-2033 20
3.5 IVD Analyzers Market, EU5, Company Share by Revenue ($m), 2024 22
4 IVD Analyzers Market, United Kingdom 24
4.1 IVD Analyzers Market, United Kingdom, Revenue ($m), 2018-2033 24
4.1.1 Clinical Chemistry Analyzers Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 26
4.1.2 Hematology Analyzers Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 28
4.1.3 Immunochemistry Analyzers Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 30
4.1.4 Next Generation Sequencers Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 32
4.1.5 Point of Care (POC) Analyzers Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 34
4.1.6 Polymerase Chain Reaction (PCR) Systems Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 36
4.2 IVD Analyzers Market, United Kingdom, Volume (Units), 2018-2033 38
4.2.1 Clinical Chemistry Analyzers Market, United Kingdom, Volume (Units), by Segment, 2018-2033 41
4.2.2 Hematology Analyzers Market, United Kingdom, Volume (Units), by Segment, 2018-2033 43
4.2.3 Immunochemistry Analyzers Market, United Kingdom, Volume (Units), by Segment, 2018-2033 45
4.2.4 Next Generation Sequencers Market, United Kingdom, Volume (Units), by Segment, 2018-2033 47
4.2.5 Point of Care (POC) Analyzers Market, United Kingdom, Volume (Units), by Segment, 2018-2033 49
4.2.6 Polymerase Chain Reaction (PCR) Systems Market, United Kingdom, Volume (Units), by Segment, 2018-2033 51
4.3 IVD Analyzers Market, United Kingdom, Average Price ($) , 2018-2033 53
4.4 IVD Analyzers Market, United Kingdom, Company Share by Revenue ($m), 2024 56
5 IVD Analyzers Market, Germany 58
5.1 IVD Analyzers Market, Germany, Revenue ($m), 2018-2033 58
5.1.1 Clinical Chemistry Analyzers Market, Germany, Revenue ($m), by Segment, 2018-2033 60
5.1.2 Hematology Analyzers Market, Germany, Revenue ($m), by Segment, 2018-2033 62
5.1.3 Immunochemistry Analyzers Market, Germany, Revenue ($m), by Segment, 2018-2033 64
5.1.4 Next Generation Sequencers Market, Germany, Revenue ($m), by Segment, 2018-2033 66
5.1.5 Point of Care (POC) Analyzers Market, Germany, Revenue ($m), by Segment, 2018-2033 68
5.1.6 Polymerase Chain Reaction (PCR) Systems Market, Germany, Revenue ($m), by Segment, 2018-2033 70
5.2 IVD Analyzers Market, Germany, Volume (Units), 2018-2033 72
5.2.1 Clinical Chemistry Analyzers Market, Germany, Volume (Units), by Segment, 2018-2033 75
5.2.2 Hematology Analyzers Market, Germany, Volume (Units), by Segment, 2018-2033 77
5.2.3 Immunochemistry Analyzers Market, Germany, Volume (Units), by Segment, 2018-2033 79
5.2.4 Next Generation Sequencers Market, Germany, Volume (Units), by Segment, 2018-2033 81
5.2.5 Point of Care (POC) Analyzers Market, Germany, Volume (Units), by Segment, 2018-2033 83
5.2.6 Polymerase Chain Reaction (PCR) Systems Market, Germany, Volume (Units), by Segment, 2018-2033 85
5.3 IVD Analyzers Market, Germany, Average Price ($) , 2018-2033 87
5.4 IVD Analyzers Market, Germany, Company Share by Revenue ($m), 2024 90
6 IVD Analyzers Market, France 92
6.1 IVD Analyzers Market, France, Revenue ($m), 2018-2033 92
6.1.1 Clinical Chemistry Analyzers Market, France, Revenue ($m), by Segment, 2018-2033 94
6.1.2 Hematology Analyzers Market, France, Revenue ($m), by Segment, 2018-2033 96
6.1.3 Immunochemistry Analyzers Market, France, Revenue ($m), by Segment, 2018-2033 98
6.1.4 Point of Care (POC) Analyzers Market, France, Revenue ($m), by Segment, 2018-2033 100
6.1.5 Polymerase Chain Reaction (PCR) Systems Market, France, Revenue ($m), by Segment, 2018-2033 102
6.2 IVD Analyzers Market, France, Volume (Units), 2018-2033 104
6.2.1 Clinical Chemistry Analyzers Market, France, Volume (Units), by Segment, 2018-2033 106
6.2.2 Hematology Analyzers Market, France, Volume (Units), by Segment, 2018-2033 108
6.2.3 Immunochemistry Analyzers Market, France, Volume (Units), by Segment, 2018-2033 110
6.2.4 Point of Care (POC) Analyzers Market, France, Volume (Units), by Segment, 2018-2033 112
6.2.5 Polymerase Chain Reaction (PCR) Systems Market, France, Volume (Units), by Segment, 2018-2033 114
6.3 IVD Analyzers Market, France, Average Price ($), 2018-2033 116
6.4 IVD Analyzers Market, France, Company Share by Revenue ($m), 2024 119
7 IVD Analyzers Market, Italy 121
7.1 IVD Analyzers Market, Italy, Revenue ($m), 2018-2033 121
7.1.1 Clinical Chemistry Analyzers Market, Italy, Revenue ($m), by Segment, 2018-2033 123
7.1.2 Hematology Analyzers Market, Italy, Revenue ($m), by Segment, 2018-2033 125
7.1.3 Immunochemistry Analyzers Market, Italy, Revenue ($m), by Segment, 2018-2033 127
7.1.4 Point of Care (POC) Analyzers Market, Italy, Revenue ($m), by Segment, 2018-2033 129
7.1.5 Polymerase Chain Reaction (PCR) Systems Market, Italy, Revenue ($m), by Segment, 2018-2033 131
7.2 IVD Analyzers Market, Italy, Volume (Units), 2018-2033 133
7.2.1 Clinical Chemistry Analyzers Market, Italy, Volume (Units), by Segment, 2018-2033 135
7.2.2 Hematology Analyzers Market, Italy, Volume (Units), by Segment, 2018-2033 137
7.2.3 Immunochemistry Analyzers Market, Italy, Volume (Units), by Segment, 2018-2033 139
7.2.4 Point of Care (POC) Analyzers Market, Italy, Volume (Units), by Segment, 2018-2033 141
7.2.5 Polymerase Chain Reaction (PCR) Systems Market, Italy, Volume (Units), by Segment, 2018-2033 143
7.3 IVD Analyzers Market, Italy, Average Price ($), 2018-2033 145
7.4 IVD Analyzers Market, Italy, Company Share by Revenue ($m), 2024 148
8 IVD Analyzers Market, Spain 150
8.1 IVD Analyzers Market, Spain, Revenue ($m), 2018-2033 150
8.1.1 Clinical Chemistry Analyzers Market, Spain, Revenue ($m), by Segment, 2018-2033 152
8.1.2 Hematology Analyzers Market, Spain, Revenue ($m), by Segment, 2018-2033 154
8.1.3 Immunochemistry Analyzers Market, Spain, Revenue ($m), by Segment, 2018-2033 156
8.1.4 Point of Care (POC) Analyzers Market, Spain, Revenue ($m), by Segment, 2018-2033 158
8.1.5 Polymerase Chain Reaction (PCR) Systems Market, Spain, Revenue ($m), by Segment, 2018-2033 160
8.2 IVD Analyzers Market, Spain, Volume (Units), 2018-2033 162
8.2.1 Clinical Chemistry Analyzers Market, Spain, Volume (Units), by Segment, 2018-2033 164
8.2.2 Hematology Analyzers Market, Spain, Volume (Units), by Segment, 2018-2033 166
8.2.3 Immunochemistry Analyzers Market, Spain, Volume (Units), by Segment, 2018-2033 168
8.2.4 Point of Care (POC) Analyzers Market, Spain, Volume (Units), by Segment, 2018-2033 170
8.2.5 Polymerase Chain Reaction (PCR) Systems Market, Spain, Volume (Units), by Segment, 2018-2033 172
8.3 IVD Analyzers Market, Spain, Average Price ($) , 2018-2033 174
8.4 IVD Analyzers Market, Spain, Company Share by Revenue ($m), 2024 178
9 Overview of Key Companies in EU5 IVD Analyzers Market 180
9.1 F. Hoffmann-La Roche Ltd 180
9.1.1 Company Overview 180
9.2 Siemens Healthineers AG 180
9.2.1 Company Overview 180
9.3 Sysmex Corp 180
9.3.1 Company Overview 180
9.4 Abbott Laboratories 181
9.4.1 Company Overview 181
9.5 Danaher Corp 181
9.5.1 Company Overview 181
9.6 Bio-Rad Laboratories Inc 181
9.6.1 Company Overview 181
9.7 Horiba Ltd 181
9.7.1 Company Overview 181
9.8 Thermo Fisher Scientific Inc 182
9.8.1 Company Overview 182
9.9 DiaSorin SpA 182
9.9.1 Company Overview 182
9.10 bioMerieux SA 182
9.10.1 Company Overview 182
10 IVD Analyzers Market Pipeline Products 183
11 Recent Developments 207
11.1 Corporate Communications 207
11.1.1 Jun 03, 2025: SenzaGen Receives New Assignment From RIFM – Confirms Successful Expansion of Testing Portfolio 207
11.1.2 Sep 10, 2024: Qlife is to Announce that Peter Warthoe will Return to the Management Group as Chief Scientific Officer 207
11.2 Financial Announcements 208
11.2.1 May 23, 2025: Angle PLC: Notice of Results 208
11.2.2 Aug 06, 2024: MaxCyte Reports Second Quarter and Half-Year 2024 Financial Results and Updates Full Year 2024 Guidance 208
11.2.3 Jul 30, 2024: SDI Group Reports Final Audited Results for Year Ended April 30, 2024 209
11.2.4 Jul 15, 2024: Boule Diagnostics – Invitation to Presentation of the Interim Report Q2 2024 210
11.2.5 Jul 05, 2024: CellaVision Report Invitation to Presentation for the Second Quarter 2024 on July 19, at 11:00 CEST 210
11.3 Legal And Regulatory 210
11.3.1 Jul 19, 2024: Qlife Holding Subsidiary Qlife APS Terminates Corporate Restructuring and Files for Bankruptcy. Qlife Holding Investigates a Capital Raise and to Submit an Offer to Repurchase the Assets 210
11.4 Other Significant Developments 211
11.4.1 Jun 04, 2025: ALIKO SCIENTIFIC Inks Exclusive Distribution Agreement With Menarini Diagnostics 211
11.4.2 Feb 05, 2025: UMC Utrecht Adopts Volta Labs Callisto Sample Prep System to Process Thousands of Samples for Whole Genome Sequencing-Based Prenatal and Postnatal Testing 211
11.4.3 Jan 30, 2025: Axsome Therapeutics Announces FDA Approval of SYMBRAVO (meloxicam and rizatriptan) for Acute Treatment of Migraine with or without Aura in Adults 212
11.4.4 Jan 07, 2025: Qlife Provides Update on Operational Progress in China 214
11.4.5 Dec 20, 2024: RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial 214
11.4.6 Oct 23, 2024: F. Hoffmann-La Roche Announces Third Quarter Sales 2024 215
11.4.7 Oct 08, 2024: NIHR Awards £30 Million to NHS to Buy Cutting Edge Research Equipment 215
11.4.8 Sep 04, 2024: Production Of Egoo Consumables Now Established In China To Support On-going Clinical Trials And Future Sales 216
11.5 Product News 216
11.5.1 Jun 04, 2025: Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse G STREM2 Assay for Research Use Only 216
11.5.2 Jan 16, 2025: Qlife Announces Introduction of a CE-Approved Joint Developed Egoo Health Platform for Immediate Sales 216
11.5.3 Nov 21, 2024: ArcticZymes' M-SAN HQ Sets New Standard for Measles Virus Purification with Unmatched DNA Clearance and High Recovery Rates 217
11.5.4 Sep 10, 2024: Merck Launches Single-Use Reactor Designed to Accelerate ADC Manufacturing 218
11.5.5 Aug 29, 2024: New Method Developed to Detect Fake Vaccines in Supply Chains 218
11.5.6 Aug 08, 2024: Genetic Analysis launches consumer microbiome testing platform through Prokarimi, powered by GA-map technology 219
11.6 Strategy And Business Planning 219
11.6.1 May 15, 2025: IMU Biosciences Adopts Curiox’s Pluto for Large-Scale UK Immune Profiling Initiative 219
11.6.2 May 13, 2025: Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics 220
11.6.3 Apr 25, 2025: Bioskryb Genomics and Tecan Introduce a Single-Cell Multiomics Workflow for Sequencing-Ready Libraries in Under Ten Hours 220
11.6.4 Feb 14, 2025: Qlife Launches Thyroid Disease and Vitamin D Biomarkers, Now Available for Immediate Sales 221
11.6.5 Oct 02, 2024: Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica to Advance the Discovery of Novel Drugs for Neurological Disease 221
11.6.6 Sep 23, 2024: Angle PLC Announces Exclusive Agreement for DNA NGS Panel 221
11.6.7 Sep 17, 2024: Progress Update: SUDPACK MEDICA’s French Site Expansion is on Schedule 222
11.6.8 Aug 08, 2024: Genetic Analysis launches consumer microbiome testing platform through Prokarimi, powered by GA-map technology 223
11.6.9 Jul 01, 2024: Artel Portfolio Expands Presence in Europe 224
12 Appendix 225
12.1 Research Methodology 226
12.1.1 Coverage 226
12.1.2 Secondary Research 226
12.1.3 Primary Research 226
12.1.4 Market Modeling and Forecasting 227
12.1.5 Company Share Analysis 228
12.1.6 Benchmarking 229
12.2 GlobalData Consulting 230
12.3 Contact Us 230
12.4 Disclaimer 230